AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 May 2011 07:00 AM
RNS
Transaction in Own Shares
06 May 2011 04:00 PM
RNS
Director/PDMR Shareholding
06 May 2011 12:30 PM
RNS
Share Repurchase Programme
06 May 2011 07:00 AM
RNS
Transaction in Own Shares
05 May 2011 07:00 AM
RNS
Transaction in Own Shares
04 May 2011 04:00 PM
RNS
Director/PDMR Shareholding
04 May 2011 04:00 PM
RNS
Director/PDMR Shareholding
04 May 2011 07:00 AM
RNS
Transaction in Own Shares
03 May 2011 04:00 PM
RNS
Total Voting Rights
03 May 2011 07:00 AM
RNS
Transaction in Own Shares
28 Apr 2011 06:15 PM
RNS
Filing of Annual Report on SEC
28 Apr 2011 05:57 PM
RNS
Result of Meeting
28 Apr 2011 07:00 AM
RNS
1st Quarter Results (part 2 of 2)
28 Apr 2011 07:00 AM
RNS
1st Quarter Results (part 1 of 2)
28 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
27 Apr 2011 09:00 AM
RNS
Notice of Results
27 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
26 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
21 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
20 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
19 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
18 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
15 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
14 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
12 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
11 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
08 Apr 2011 04:30 PM
RNS
Annual Information Update
08 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
07 Apr 2011 07:00 AM
RNS
FDA Approval for Vandetanib
07 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
06 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
05 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
04 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
01 Apr 2011 04:00 PM
RNS
Total Voting Rights
01 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
31 Mar 2011 05:30 PM
RNS
Director/PDMR Shareholding
31 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
28 Mar 2011 08:00 AM
RNS
UK and US reach agreement over tax matters
28 Mar 2011 08:00 AM
RNS
Transaction in Own Shares
28 Mar 2011 07:00 AM
RNS
UK and US reach agreement over tax matters
28 Mar 2011 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100